{"id":"W4376613897","doi":"10.1016/j.esmoop.2023.101392","title":"203P Clinical effectiveness of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer (mBC) by ER expression level: Subgroup analysis from phase IIIb LUCY trial","year":2023,"lang":"en","type":"article","venue":"ESMO Open","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; University of British Columbia","funders":"Yonsei University College of Medicine; Merck Sharp and Dohme; Fundació Institut de Recerca Hospital Universitari Vall d’Hebron; Universitat de Barcelona; Medizinischen Hochschule Hannover; Hacettepe Üniversitesi; Gilead Sciences; Merck; AstraZeneca","keywords":"Medicine; Olaparib; Internal medicine; Oncology; Metastatic breast cancer; Taxane; Eribulin; Breast cancer; Population; Vinorelbine; Cancer; Chemotherapy; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003165975,0.001094437,0.00340165,0.00048988,0.0002554001,0.001256428,0.0005920338,0.001020759,0.002937067],"category_scores_gemma":[0.00236984,0.0002978329,0.006388021,0.0006070614,0.0004013924,0.0005976301,0.0004947772,0.001358365,0.0004514438],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007233374,"about_ca_system_score_gemma":0.0006651322,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008029718,"about_ca_topic_score_gemma":0.0021371,"domain_scores_codex":[0.998321,0.0009687243,0.0001788462,0.0002018926,0.0001325108,0.0001969921],"domain_scores_gemma":[0.9987522,0.0005465069,0.0002432235,0.0001872423,0.00008452243,0.000186219],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.9347996,0.000775401,0.01669855,0.001088134,0.01528306,0.000226559,0.00005691243,0.001112634,0.005920074,0.0001168724,0.00215478,0.02176744],"study_design_scores_gemma":[0.620341,0.1195377,0.1961002,0.0004094754,0.04275789,0.0009219437,0.0002496454,0.005301515,0.004336964,0.002486761,0.007386196,0.0001706545],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9785433,0.01204821,0.0007418414,0.0006446121,0.0001990534,0.001251783,0.004504461,0.00006801429,0.001998659],"genre_scores_gemma":[0.9920923,0.00142383,0.000434398,0.0006680194,0.0002126194,0.0009578679,0.003425868,0.00002440539,0.0007606348],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00340165,"threshold_uncertainty_score":0.01674348,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09030039216248577,"score_gpt":0.4620253913515751,"score_spread":0.3717249991890894,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}